This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, compliance and secondary packaging services, has completed its move into a modernized 190,000-square-foot production facility. The new plant, which also will serve as the company’s headquarters, is more than twice the size of its previous facility, making room for a variety of additions and upgrades to Legacy’s production and customer servicing capabilities, including ten new packaging lines.
This spacious facility also contains a new Drug Enforcement Administration-approved Schedule II vault that can hold up to 300 pallets of product. The DEA vault fully meets federal regulation code 21CFR 1301.72, the governing specification for pharmaceutical applications. The plant has Verified-Accredited Wholesale Distributor status, which pertains to Legacy’s enhanced abilities to prevent potentially counterfeit drugs from entering the U.S. drug supply. To gain VAWD accreditation, wholesale distributors undergo a rigorous review of operating policies and procedures, licensure verification, surveys of facility and operations, background checks and screening.
Legacy’s new headquarters will also house a state-of-the-art 1,500-square-foot training facility which provides a dedicated area to train equipment operators and packaging specialists without interrupting day-to-day operations.
“The new facility exemplifies our commitment to anticipating and investing in our customers’ future needs,” said Brad Rayner, Executive Director of Sales & Marketing for Legacy Pharmaceutical Packaging. “This marks the largest infrastructure upgrade and expansion in Legacy’s history, leaving us well-positioned for further growth to both our client portfolio and overall service capabilities.”
